CN104606427A - Schefflera arboricola-contained traditional Chinese medicinal composition - Google Patents
Schefflera arboricola-contained traditional Chinese medicinal composition Download PDFInfo
- Publication number
- CN104606427A CN104606427A CN201410818017.8A CN201410818017A CN104606427A CN 104606427 A CN104606427 A CN 104606427A CN 201410818017 A CN201410818017 A CN 201410818017A CN 104606427 A CN104606427 A CN 104606427A
- Authority
- CN
- China
- Prior art keywords
- schefflerae arboricolae
- radix
- parts
- folium
- caulis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a schefflera arboricola-contained traditional Chinese medicinal composition. The schefflera arboricola-contained traditional Chinese medicinal composition comprises the following Chinese herbal raw materials in parts by weight: 20-50 parts of schefflera arboricola, 20-40 parts of shinyleaf pricklyash, 10-30 parts of small centipeda herb, 10-30 parts of callicarpa macrophylla, 8-20 parts of rhizoma cyperi, 8-20 parts of bighead atractylodes rhizome, 5-15 parts of rhizoma corydalis and 5-15 parts of liquorice. The traditional Chinese medicinal composition has the effects of regulating stomach and removing painful abdominal mass, warming spleen and stomach for dispelling cold, invigorating the spleen and drying dampness, promoting blood circulation for removing blood stasis, and promoting Qi circulation for relieving pains, can significantly improve fullness, pains and belching of an upper abdomen of a patient, oral dryness, noisiness, acid regurgitation and other chronic gastritis symptoms, has small side effects and has no adverse reactions.
Description
Technical field
The invention belongs to medicine field, relate to a kind of Chinese medicine composition containing Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae).
Background technology
Modern owing to being busy with one's work, often staying up late, at ordinary times diet not note etc. reason causing the health of a lot of people to be all in sub-health state, as chronic gastritis.Chronic gastritis is common clinical, frequently-occurring disease, its etiology and pathogenesis is illustrated so far not yet completely, modern medicine is illustrated not yet about the cause of disease of chronic gastritis, think that its basic pathogenesis is peracid, helicobacter pylori, it is unbalance that immunity waits many factors to cause stomach to bore between the infringement of film and protection factor, based on symptomatic treatment in treatment, comprise antacid, anti-HP, strengthen mucous membrane protection, promote gastric peristalsis, reduce the hands sections such as Duodenal reflux, along with the appearance of various efficient antacid new drug, treatment chronic gastritis obtains good curative effect, but relapse rate still can be in any more, and majority has the medicine of definite curative effect, long-term taking has again many untoward reaction, so anxious to be developed go out one can ensure curative effect, relapse rate can be reduced again, and the medicine that untoward reaction is slight.Chinese medicine gastritis few side effects, not easily produces drug resistance, treating both the principal and secondary aspects of a disease, has unique advantage and potential.The present invention, through long term accumulation, works out a kind of Chinese medicine composition containing Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), effectively can improve symptom, can reduce recurrence again, at present, there is not yet relevant report.
(1) Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), is Araliaceae Schefflera plant schefflera arboricola Scheffleva arboricola Hayata and Schefflera venulosa (Wight et Arn.) Harms S.venulosa (Wight et Arn.) Harms, is used as medicine with stem and leaf.Record in Chinese Pharmacopoeia version in 1977: [nature and flavor] acrid in the mouth; Micro-hardship; Warm in nature.[function with cure mainly] wind-expelling pain-stopping; Promoting blood circulation and detumescence.Main air pain of dampness syndrome; Headache; Toothache; Epigastric pain; Dysmenorrhea; Puerperal abdonimal pain; Treating swelling and pain by traumatic injury; Fracture; Skin ulcer swells.
(2) Radix Zanthoxyli is the dry root of rutaceae Radix Zanthoxyli Zanthor μ lum nitidum (Roxb.) DC..Record in Chinese Pharmacopoeia version in 2010: [nature and flavor with return through] are bitter, pungent, flat.Return liver, stomach warp.[function with cure mainly] blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, dispelling wind and removing obstruction in the collateral, removing toxic substances and promoting subsidence of swelling.For injury from falling down, stomachache, toothache, rheumatic arthralgia, venom; Externally treating burns and scalds.Modern study shows, the two sides crown is mainly containing containing the chemical compositions such as alkaloid, diosmin, coumarin, sterin, flavonoid glycoside, aminoacid.Radix Zanthoxyli Chinese medicine extract antiinflammatory, analgesia, anti-mattress, to cardiovascular system, spasmolytic, anticancer etc. in all have effect.
(3) Herba Centipedae is the dry herb of feverfew Herba Centipedae Centipeda minima (L.) A.Br.et Aschers..Record in Chinese Pharmacopoeia version in 2010: [nature and flavor with return through] are pungent, temperature.Return lung meridian.[function with cure mainly] dispersing wind-cold, clearing the nasal passage, cough-relieving.For headche due to wind-cold, cough with copious phlegm, has a stuffy nose obstructed, nasal sinusitis watery nasal discharge.
(4) Folium Callicarpae Macrophyllae is dried leaves or the band leaf twig of Verbenaceae Folium Callicarpae Macrophyllae Callicarpa macroph μ llaVahl.Record in Chinese Pharmacopoeia version in 2010: [nature and flavor with return through] are pungent, bitter, flat.Return liver, lung, stomach warp.[function with cure mainly] dissipating blood stasis stops blooding, reducing swelling and alleviating pain.For epistaxis, spitting of blood, spits blood, has blood in stool, traumatic hemorrhage, tumbling and swelling.
(5) Rhizoma Cyperi is the dry rhizome of sedge dried tuber Cyperus rotundus L..Record in Chinese Pharmacopoeia version in 2010: [nature and flavor with return through] pungent, micro-hardship, micro-sweet, flat.Return liver, spleen, tri-jiao channel.[function with cure mainly] dispersing the stagnated live-QI to relieve the stagnation of QI, regulating the flow of QI to ease the stomach, menstruction regulating and pain relieving.For stagnation of QI due to depression of the liver, distending pain in the chest and hypochondrium, hernia pain, distending pain of the breast, stagnation of QI in spleen and stomach, gastral cavity abdomen painful abdominal mass is vexed, distension pain, menoxenia, amenorrhea dysmenorrhea.
(6) Rhizoma Atractylodis Macrocephalae is the dry rhizome of feverfew Rhizoma Atractylodis Macrocephalae Atract μ lodes macrocephala Koidz..Record in Chinese Pharmacopoeia version in 2010: [nature and flavor with return through] are bitter, sweet, temperature.Return spleen, stomach warp.[function with cure mainly] invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.
(7) Rhizoma Corydalis is the dry tuber of papaveraceae plant corydalis Corydalis yanhusuo W.T.Wang.Record in Chinese Pharmacopoeia version in 2010: [nature and flavor with return through] are pungent, bitter, temperature.Return liver, spleen channel.[function with cure mainly] invigorates blood circulation, circulation of qi promoting, pain relieving.For the breast side of body, epigastric pain, obstruction of qi in the chest and cardialgia, amenorrhea dysmenorrhea, postpartum stagnation, tumbling and swelling.
(8) Radix Glycyrrhizae is the dry root and rhizome of glycyrrhizic legume Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat. Glycyrrhizainflata Bat. or Glycyrrhiza glabra L. Glycyrrhiza glabra L..[nature and flavor with return through] are sweet, flat, GUIXIN, lung, spleen, stomach warp; [function with cure mainly] invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription, for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, the anxious pain of gastral cavity abdomen extremity contraction, carbuncle sore tumefacting virus, abirritant physical property, strong.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition treating chronic gastritis containing Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae).
The technical solution adopted in the present invention is as follows:
Containing a Chinese medicine composition for Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), raw material is made up of the Chinese medicinal components of following weight portion: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 20-50 part, Radix Zanthoxyli 20-40 part, Herba Centipedae 10-30 part, Folium Callicarpae Macrophyllae 10-30 part, Rhizoma Cyperi 8-20 part, Rhizoma Atractylodis Macrocephalae 8-20 part, Rhizoma Corydalis 5-15 part, Radix Glycyrrhizae 5-15 part.
The above is containing the Chinese medicine composition of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), and raw material is preferably made up of the Chinese medicinal components of following weight portion: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 30-40 part, Radix Zanthoxyli 25-35 part, Herba Centipedae 15-25 part, Folium Callicarpae Macrophyllae 15-25 part, Rhizoma Cyperi 10-18 part, Rhizoma Atractylodis Macrocephalae 8-20 part, Rhizoma Corydalis 8-12 part, Radix Glycyrrhizae 8-12 part; Raw material the best is preferably made up of the Chinese medicinal components of following weight portion: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 35 parts, Radix Zanthoxyli 30 parts, Herba Centipedae 20 parts, Folium Callicarpae Macrophyllae 20 parts, Rhizoma Cyperi 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, Rhizoma Corydalis 10 parts, 10 parts, Radix Glycyrrhizae.
The above is containing the Chinese medicine composition of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), acceptable excipient on various pharmaceuticss required when preparing different dosage form can be added, as disintegrating agent, lubricant, binding agent, cosolvent, thickening agent, antiseptic etc., and be prepared into pharmaceutically acceptable any dosage form with modern Chinese medicine formulation method.Such as, be mixed and made into powder after each raw material of Chinese medicine directly can being pulverized; Also by these crude drug water or with processing accordingly after ethanol extraction and adding the different auxiliary material needed for the different solid preparation of preparation, the day oral solid preparation that capsule, tablet, pill, powder, drop pill, granule etc. are multi-form can namely be can be made into; Also by these crude drug water or with processing accordingly after ethanol extraction and adding the different auxiliary material prepared needed for different liquids preparation, the oral liquid that mixture, syrup, Emulsion etc. are multi-form can namely be can be made into.As preferably, described dosage form is capsule.
The above Chinese medicine composition containing Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) makes the preparation method of capsule, comprises the following steps:
1. take component respectively by weight: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 20-50 part, Radix Zanthoxyli 20-40 part, Herba Centipedae 10-30 part, Folium Callicarpae Macrophyllae 10-30 part, Rhizoma Cyperi 8-20 part, Rhizoma Atractylodis Macrocephalae 8-20 part, Rhizoma Corydalis 5-15 part, Radix Glycyrrhizae 5-15 part;
2. get Rhizoma Corydalis and be ground into fine powder, cross 80 mesh sieves, obtain first English white;
3. get Herba Centipedae, Rhizoma Cyperi extracts volatile oil, for subsequent use; Medicinal residues and Radix Zanthoxyli, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Folium Callicarpae Macrophyllae, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, add 6-10 times of water gaging, heating extraction 2-3 time, each 1-2 hour, filter, merging filtrate, filtrate is condensed into thick paste, adds the first English white under step 2 and appropriate amount of starch, dry, pulverize, get dry extract powder;
4. get the volatile oil under step 3, with 6-10 times amount betacyclodextrin inclusion his cyclodextrin inclusion complex at double, add in step 3 dried cream powder, add magnesium stearate, microcrystalline Cellulose, mixing, incapsulates, to obtain final product.
Chinese medicine composition of the present invention is made up of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Radix Zanthoxyli, Herba Centipedae, Folium Callicarpae Macrophyllae, Rhizoma Cyperi, the Rhizoma Atractylodis Macrocephalae, Rhizoma Corydalis, Radix Glycyrrhizae, all medicines are harmonious, gather altogether and diabetes involving middle-JIAO painful abdominal mass, warming spleen and stomach for dispelling cold, the spleen strengthening and damp drying, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain merit, there is well treatment gastritis effect.The consumption of pharmaceutical composition of the present invention is also through inventor and gropes in a large number to sum up, repeatedly study and verify preferably and obtain, show through clinical trial: the present invention treats chronic gastritis significant curative effect, effective percentage reaches 97%, can obviously improve patient's epigastrium full vexed, pain, belch, xerostomia, noisy, pantothenic acid, weak, become thin, the symptom such as lack of appetite, and side effect is little, during medication, there is not the untoward reaction such as gastrointestinal tract, allergy.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but do not limit the scope of the invention and range of application:
One, the preparation method of capsule is made containing the Chinese medicine composition of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae)
1. EXPERIMENTAL DESIGN:
This test 5 embodiments are prepared into capsule respectively, and design parameter refers to table 1.
Table 1 capsule embodiment preparation parameter table
| Embodiment | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 |
| Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) (kg) | 20 | 50 | 40 | 30 | 35 |
| Radix Zanthoxyli (kg) | 20 | 40 | 35 | 25 | 30 |
| Herba Centipedae (kg) | 10 | 30 | 25 | 15 | 20 |
| Rhizoma Cyperi (kg) | 8 | 20 | 18 | 10 | 15 |
| Folium Callicarpae Macrophyllae (kg) | 10 | 30 | 25 | 15 | 20 |
| The Rhizoma Atractylodis Macrocephalae (kg) | 8 | 20 | 18 | 10 | 15 |
| Rhizoma Corydalis (kg) | 5 | 15 | 12 | 8 | 10 |
| Radix Glycyrrhizae (kg) | 5 | 15 | 12 | 8 | 10 |
| Extract amount of water (doubly) | 6 | 8 | 10 | 7 | 8 |
| Extraction time (secondary) | 3 | 2 | 2 | 3 | 2 |
| Time (h/ time) | 1 | 2 | 1.5 | 1 | 2 |
| Relative density (60 DEG C) | 1.25 | 1.28 | 1.26 | 1.32 | 1.30 |
| Betacyclodextrin amount (doubly) | 6 | 8 | 7 | 8 | 6 |
2. operating procedure:
(1) take respectively by table 1 weight portion: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Radix Zanthoxyli, Herba Centipedae, Folium Callicarpae Macrophyllae, Rhizoma Cyperi, the Rhizoma Atractylodis Macrocephalae, Rhizoma Corydalis, Radix Glycyrrhizae;
(2) get Rhizoma Corydalis and be ground into fine powder, cross 80 mesh sieves, obtain first English white;
(3) get Herba Centipedae, Rhizoma Cyperi extracts volatile oil, for subsequent use; Medicinal residues and Radix Zanthoxyli, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Folium Callicarpae Macrophyllae, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, add 6-10 times of water gaging, heating extraction 2-3 time, each 1-2 hour, filters, merging filtrate, filtrate is condensed into the thick paste that relative density is 1.25 ~ 1.32 (60 DEG C), adds the first English white under step (2) and appropriate amount of starch, dry, pulverize, get dry extract powder;
(4) get the volatile oil under step (3), with 6-10 times amount betacyclodextrin inclusion his cyclodextrin inclusion complex at double, add in step (3) dried cream powder, add magnesium stearate, microcrystalline Cellulose, mixing, incapsulates, to obtain final product.
Three, clinical practice
1. case selection standard
All cases all meet the diagnostic criteria that digestive endoscopy branch of Chinese Medical Association works out " the endoscopic classification grade scale of chronic gastritis and the tentative suggestion for the treatment of " in 2003.
(1) clinical cardinal symptom: the epigastrium of prolonged and repeated generation full vexed, pain, belch, xerostomia, noisy, pantothenic acid.Have a medical check-up and can have the mild tenderness of epigastrium, without muscle tonus and rebound tenderness.
(2) gastroscope prompting has superficial gastritis or erosive gastritis or reflux gastritis.
(3) inclusive criteria:
A. the age is between 18-65 year.
B. before medication, 1-2 week is interior through gastroscope, pathologic finding prover.
C. can partner treatment, the patient of further consultation on time.
(4) exclusion standard
A. the age is under-18s or over-65s person.
B. peptic ulcer is merged, digestive system carcinoma, the doubtful person of cancerating of pathological diagnosis.
C. severe primary disease, the abdomens such as Progressive symmetric erythrokeratodermia scleroderma, the heart, cerebrovascular, Liver and kidney and hemopoietic system is merged
Portion performs the operation, psychotic.
D. gestation or preparation gravid woman, women breast-feeding their children.
E. allergic constitution or to multi-medicament allergy sufferers.
F. not by regulation medication or therapy discontinued, cannot judge that curative effect or data are not congruent and affect the treatment or safety judgement person.
2. therapeutic scheme
(1) embodiment group: by above-mentioned embodiment 5 sample prepared, for clinical trial.Oral, one time 5,3 times on the one.The course for the treatment of: medication 45 days.
(2) matched group: cubic stomach sheet (commercially available).Oral, one time 3,3 times on the one.The course for the treatment of: medication 45 days.
3. efficacy assessment standard
Integration × 100% before therapeutic index=(treat front integration one and treat rear integration)/treatment
(1) fully recover: clinical cardinal symptom disappears or substantially disappears, therapeutic index >=95%; Gastroscopy ulcer and around inflammation all disappear, and are cicatrix.
(2) improve: clinical cardinal symptom take a favorable turn, therapeutic index >=30%; Gastroscopy ulcer surface reduces more than 50%.
(3) invalid: clinical cardinal symptom without improvement, therapeutic index < 30%; Gastroscopy ulcer surface reduces not as good as 50%.
4. result of the test: be used for the treatment of and observe 68 routine outpatients.By above-mentioned embodiment 5 sample for preparing and cubic stomach sheet, be respectively used to patient: treatment group: 38 examples (man 18 example, female 20 example, 41.4 years old mean age), matched group 30 example (man 13 example, female 17 example, 41.8 years old mean age), the results detailed in Table 2.
Table 2 clinical trial result table
Result shows: adopt the embodiment of the present invention 5 to treat, cure rate is 81%, effective percentage reaches 97%, general effect is suitable with matched group, do not have untoward reaction to occur, use safety, effectively, can obviously improve patient's epigastrium full vexed, pain, belch, xerostomia, noisy, pantothenic acid, weak, become thin, the symptom such as lack of appetite, favourable prognosis, without recurrence.Be below several model case:
Case 1: thank to ××, female, 36 years old, epigastrium pain, abdominal distention, vomiting, weak, become thin.Gastroscopy, gastric mucosa is congested, ulcer.Take the embodiment of the present invention 5, each 5, every day 3 times, serve on 45, above symptom is eliminated, gastroscopy, has no stomach congested and rotten to the corn, recovery from illness.Pay a return visit after 1 year, have no recurrence.
Case 2: wish ××, man, 32 years old, epigastrium was glutted, dull pain, belch acid regurgitation.Gastroscopy gastric mucosa is congested.Take the embodiment of the present invention 5, each 5, every day 3 times, take 5, dull pain symptom is eliminated, and take 10, glutted, belch acid regurgitation symptom is obviously improved, and serve on 45, transference cure, recovery from illness.Pay a return visit after 1 year, have no recurrence.
Case 3: Feng's ××, man, 43 years old, before or after meals stomach dull pain, existing half a year, hospital gastroscope check result: superficial gastritis.Take the embodiment of the present invention 5, each 5, every day 3 times, serve on 45, gastritis transference cure, recovery from illness.Pay a return visit after 1 year, have no recurrence.
Claims (6)
1. the Chinese medicine composition containing Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), it is characterized in that, raw material is made up of the Chinese medicinal components of following weight portion: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 20-50 part, Radix Zanthoxyli 20-40 part, Herba Centipedae 10-30 part, Folium Callicarpae Macrophyllae 10-30 part, Rhizoma Cyperi 8-20 part, Rhizoma Atractylodis Macrocephalae 8-20 part, Rhizoma Corydalis 5-15 part, Radix Glycyrrhizae 5-15 part.
2. according to claim 1 containing the Chinese medicine composition of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), it is characterized in that, raw material is made up of the Chinese medicinal components of following weight portion: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 30-40 part, Radix Zanthoxyli 25-35 part, Herba Centipedae 15-25 part, Folium Callicarpae Macrophyllae 15-25 part, Rhizoma Cyperi 10-18 part, Rhizoma Atractylodis Macrocephalae 8-20 part, Rhizoma Corydalis 8-12 part, Radix Glycyrrhizae 8-12 part.
3. according to claim 1 containing the Chinese medicine composition of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), it is characterized in that, raw material is made up of the Chinese medicinal components of following weight portion: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 35 parts, Radix Zanthoxyli 30 parts, Herba Centipedae 20 parts, Folium Callicarpae Macrophyllae 20 parts, Rhizoma Cyperi 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, Rhizoma Corydalis 10 parts, 10 parts, Radix Glycyrrhizae.
4., according to claim 1 containing the Chinese medicine composition of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), it is characterized in that, described Chinese medicine composition is prepared into pharmaceutically acceptable any dosage form.
5., according to claim 4 containing the Chinese medicine composition of Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), it is characterized in that, described dosage form is capsule.
6. the Chinese medicine composition containing Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) as claimed in claim 1 makes a preparation method for capsule, it is characterized in that, comprises the following steps:
(1) component is taken respectively by weight: Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 20-50 part, Radix Zanthoxyli 20-40 part, Herba Centipedae 10-30 part, Folium Callicarpae Macrophyllae 10-30 part, Rhizoma Cyperi 8-20 part, Rhizoma Atractylodis Macrocephalae 8-20 part, Rhizoma Corydalis 5-15 part, Radix Glycyrrhizae 5-15 part;
(2) get Rhizoma Corydalis and be ground into fine powder, cross 80 mesh sieves, obtain first English white;
(3) get Herba Centipedae, Rhizoma Cyperi extracts volatile oil, for subsequent use; Medicinal residues and Radix Zanthoxyli, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae), Folium Callicarpae Macrophyllae, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, add 6-10 times of water gaging, heating extraction 2-3 time, each 1-2 hour, filter, merging filtrate, filtrate is condensed into thick paste, adds the first English white under step (2) and appropriate amount of starch, dry, pulverize, get dry extract powder;
(4) get the volatile oil under step (3), with 6-10 times amount betacyclodextrin inclusion his cyclodextrin inclusion complex at double, add in step (3) dried cream powder, add magnesium stearate, microcrystalline Cellulose, mixing, incapsulates, to obtain final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410818017.8A CN104606427A (en) | 2014-12-24 | 2014-12-24 | Schefflera arboricola-contained traditional Chinese medicinal composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410818017.8A CN104606427A (en) | 2014-12-24 | 2014-12-24 | Schefflera arboricola-contained traditional Chinese medicinal composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104606427A true CN104606427A (en) | 2015-05-13 |
Family
ID=53141247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410818017.8A Pending CN104606427A (en) | 2014-12-24 | 2014-12-24 | Schefflera arboricola-contained traditional Chinese medicinal composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104606427A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105147765A (en) * | 2015-10-27 | 2015-12-16 | 丘泰西 | Schefflera arboricola wine and preparation method thereof |
-
2014
- 2014-12-24 CN CN201410818017.8A patent/CN104606427A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 余瀛鳌: "《内科通治方》", 31 January 2010, 中国医药科技出版社 * |
| 苏广洵: "《中国民间常用中草药选编 上 》", 30 April 2006, 泰国宋卡府合艾市参蒙印刷厂 * |
| 黄燮才: "《脾胃病中草药原色图谱 》", 31 December 2008, 广西科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105147765A (en) * | 2015-10-27 | 2015-12-16 | 丘泰西 | Schefflera arboricola wine and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN105055950A (en) | Chinese herbal preparation for treating recurrent oral ulceration and preparation method of Chinese herbal preparation | |
| CN103432559A (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN109529010B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and application thereof | |
| CN107737288B (en) | Traditional Chinese medicine composition for treating allergic asthma and preparation method thereof | |
| CN110339276A (en) | Traditional Chinese medicine for treating digestive tract tumor and preparation method thereof | |
| CN105497780A (en) | Decoction for harmonizing stomach, protecting mucosa and relieving pain | |
| CN104998162A (en) | Medicine for treating cough and preparing method of medicine | |
| CN103920114A (en) | Traditional Chinese medicinal composition for treating pulmonary fibrosis | |
| CN104606427A (en) | Schefflera arboricola-contained traditional Chinese medicinal composition | |
| CN104587122A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104606377A (en) | Traditional Chinese medicinal composition for treating gastritis | |
| CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
| CN104606426A (en) | Traditional Chinese medicinal composition preparation for treating chronic gastritis and preparation method thereof | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN104491316B (en) | A kind of Chinese medicine preparation for the treatment of deficiency of QI in middle-JIAO type hyperplasia of prostate | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN104587121A (en) | Traditional Chinese medicine preparation containing scandent schefflera stem and leaf and preparation method thereof | |
| CN104606378A (en) | Shinyleaf pricklyash-contained traditional Chinese medicinal composition | |
| CN104587067A (en) | Traditional Chinese medicine preparation containing shinyleaf pricklyash root and preparation method thereof | |
| CN104606375A (en) | Traditional Chinese medicinal composition for treating gastric ulcer | |
| CN106806680A (en) | Raw white side's prepared slices of Chinese crude drugs combination preparation, preparation method and assembly packaging | |
| CN104606379A (en) | Traditional Chinese medicinal composition preparation for treating gastritis and preparation method thereof | |
| CN104606376A (en) | Traditional Chinese medicinal composition preparation for treating gastric ulcer and preparation method thereof | |
| CN105709005A (en) | Breast rehabilitation promoting pill |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150513 |
|
| RJ01 | Rejection of invention patent application after publication |